PMGC (ELAB) Competitors $1.95 -0.14 (-6.70%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$2.01 +0.06 (+3.08%) As of 08/1/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFDA EventsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock ELAB vs. PHIO, CSCI, GOVX, BCDA, TRIB, ACXP, HOOK, IBIO, AIMD, and XFORShould you be buying PMGC stock or one of its competitors? The main competitors of PMGC include Phio Pharmaceuticals (PHIO), COSCIENS Biopharma (CSCI), GeoVax Labs (GOVX), BioCardia (BCDA), Trinity Biotech (TRIB), Acurx Pharmaceuticals (ACXP), HOOKIPA Pharma (HOOK), iBio (IBIO), Ainos (AIMD), and X4 Pharmaceuticals (XFOR). These companies are all part of the "pharmaceutical products" industry. PMGC vs. Its Competitors Phio Pharmaceuticals COSCIENS Biopharma GeoVax Labs BioCardia Trinity Biotech Acurx Pharmaceuticals HOOKIPA Pharma iBio Ainos X4 Pharmaceuticals Phio Pharmaceuticals (NASDAQ:PHIO) and PMGC (NASDAQ:ELAB) are both small-cap pharmaceutical products companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, dividends, institutional ownership, risk, media sentiment, profitability, analyst recommendations and earnings. Does the media refer more to PHIO or ELAB? In the previous week, PMGC had 3 more articles in the media than Phio Pharmaceuticals. MarketBeat recorded 3 mentions for PMGC and 0 mentions for Phio Pharmaceuticals. PMGC's average media sentiment score of 0.01 beat Phio Pharmaceuticals' score of 0.00 indicating that PMGC is being referred to more favorably in the news media. Company Overall Sentiment Phio Pharmaceuticals Neutral PMGC Neutral Do analysts recommend PHIO or ELAB? Phio Pharmaceuticals currently has a consensus target price of $14.00, indicating a potential upside of 500.86%. Given Phio Pharmaceuticals' stronger consensus rating and higher probable upside, equities analysts clearly believe Phio Pharmaceuticals is more favorable than PMGC.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Phio Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00PMGC 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has stronger earnings & valuation, PHIO or ELAB? Phio Pharmaceuticals is trading at a lower price-to-earnings ratio than PMGC, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPhio PharmaceuticalsN/AN/A-$7.15M-$6.42-0.36PMGCN/AN/A-$6.25M-$433.870.00 Do insiders and institutionals believe in PHIO or ELAB? 57.3% of Phio Pharmaceuticals shares are owned by institutional investors. Comparatively, 22.2% of PMGC shares are owned by institutional investors. 0.6% of Phio Pharmaceuticals shares are owned by insiders. Comparatively, 0.6% of PMGC shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Is PHIO or ELAB more profitable? PMGC's return on equity of -77.80% beat Phio Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Phio PharmaceuticalsN/A -105.65% -89.19% PMGC N/A -77.80%-59.17% Which has more volatility and risk, PHIO or ELAB? Phio Pharmaceuticals has a beta of 0.86, suggesting that its share price is 14% less volatile than the S&P 500. Comparatively, PMGC has a beta of 0.13, suggesting that its share price is 87% less volatile than the S&P 500. SummaryPMGC beats Phio Pharmaceuticals on 7 of the 13 factors compared between the two stocks. Get PMGC News Delivered to You Automatically Sign up to receive the latest news and ratings for ELAB and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ELAB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ELAB vs. The Competition Export to ExcelMetricPMGCDIVERSIFIED OPS IndustryMulti-Sector SectorNASDAQ ExchangeMarket Cap$2.88M$15.83B$14.55B$9.54BDividend YieldN/A4.20%3.97%4.09%P/E Ratio0.009.227.8023.83Price / SalesN/A4.854.0366.02Price / CashN/A33.5032.1457.96Price / Book0.172.272.005.54Net Income-$6.25M$951.84M$922.55M$259.28M7 Day Performance-14.47%-3.41%-2.98%-4.68%1 Month Performance-15.58%0.52%-0.31%4.36%1 Year Performance-99.64%6.52%4.45%17.88% PMGC Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ELABPMGC0.3541 of 5 stars$1.95-6.7%N/A-99.7%$2.88MN/A0.0018News CoverageShort Interest ↑Gap DownPHIOPhio Pharmaceuticals2.562 of 5 stars$2.58+1.9%$14.00+442.8%-21.4%$12.34MN/A-0.4010CSCICOSCIENS BiopharmaN/A$3.92+0.4%N/AN/A$12.33M$9.59M-0.6820Positive NewsGap UpGOVXGeoVax Labs2.4657 of 5 stars$0.76+2.6%$8.88+1,068.4%-65.7%$12.10M$5.59M-0.2110News CoverageEarnings ReportAnalyst ForecastAnalyst RevisionBCDABioCardia2.9094 of 5 stars$2.20-4.1%$25.00+1,039.0%-28.0%$12.08M$3K-0.9440Negative NewsShort Interest ↑TRIBTrinity Biotech1.0257 of 5 stars$0.66-1.4%N/A-75.3%$11.99M$61.56M-0.23480Gap UpACXPAcurx Pharmaceuticals2.6202 of 5 stars$0.39-5.6%$8.00+1,977.9%-85.7%$11.41MN/A-0.553News CoverageHOOKHOOKIPA Pharma3.0719 of 5 stars$0.93+1.6%$4.50+382.3%-83.9%$11.37M$43.95M-0.16160Upcoming EarningsGap DownIBIOiBio1.3151 of 5 stars$0.69-3.5%$5.00+629.9%-68.0%$11.32M$375K0.00100News CoverageAIMDAinos0.8843 of 5 stars$2.61-2.6%N/A-25.3%$10.94M$20K-0.4040Upcoming EarningsAnalyst UpgradeXFORX4 Pharmaceuticals4.5103 of 5 stars$1.89-11.5%$72.33+3,737.3%-93.1%$10.91M$2.56M0.8880Positive NewsUpcoming EarningsHigh Trading Volume Related Companies and Tools Related Companies PHIO Alternatives CSCI Alternatives GOVX Alternatives BCDA Alternatives TRIB Alternatives ACXP Alternatives HOOK Alternatives IBIO Alternatives AIMD Alternatives XFOR Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ELAB) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredToo busy to trade? Good.Too busy to trade? That might be your edge. This after-hours strategy is built for people who don’t sit at ...Timothy Sykes | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PMGC Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PMGC With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
